𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines

✍ Scribed by Jens Wagenblast; Mehran Baghi; Christoph Arnoldner; Sotirios Bisdas; Wolfgang Gstöttner; Hanns Ackermann; Angelika May; Markus Hambek; Rainald Knecht


Book ID
106123947
Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
343 KB
Volume
135
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Butyrate response factor 1 enhances cisp
✍ Seung Koo Lee; Seong Bum Kim; Jong Soo Kim; Chang Hoon Moon; Myung Shin Han; Byu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB 👁 1 views

Cisplatin is a widely used chemotherapeutic agent in head and neck squamous cell carcinoma (HNSCC). Resistance to cisplatin is a common feature of HNSCC. To identify genes that may regulate cisplatin sensitivity, we carried out a cDNA microarray analysis of gene expression in cisplatin-sensitive and